Évaluer le rapport bénéfices/risques de la vaccination contre l'hépatite B en France en 2006
- 31 January 2006
- journal article
- abstracts
- Published by Elsevier in La Revue de Médecine Interne
- Vol. 27 (1) , 40-45
- https://doi.org/10.1016/j.revmed.2005.06.001
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Long?Term Immunogenicity and Efficacy of Universal Hepatitis B Virus Vaccination in TaiwanThe Journal of Infectious Diseases, 2003
- Observational study of vaccine efficacy 14 years after trial of hepatitis B vaccination in Gambian childrenBMJ, 2002
- Are booster immunisations needed for lifelong hepatitis B immunity?The Lancet, 2000
- Six years of sentinel surveillance of hepatitis B in general practice in France.European Journal of Epidemiology, 1998
- Efficacy of a High and Accelerated Dose of Hepatitis B Vaccine in Alcoholic PatientsThe American Journal of Medicine, 1997
- Universal Hepatitis B Vaccination in Taiwan and the Incidence of Hepatocellular Carcinoma in ChildrenNew England Journal of Medicine, 1997
- Hepatitis B vaccine responsiveness in Connecticut public safety personnelPublished by American Medical Association (AMA) ,1993
- Risk factors for lack of detectable antibody following hepatitis B vaccination of Minnesota health care workersJAMA, 1993
- Hepatitis B vaccination: protection for how long and against what?BMJ, 1993
- Suboptimal response to hepatitis B vaccine in drug usersArchives of internal medicine (1960), 1991